Conno Biopharmaceutical Co., Ltd.-B has submitted a listing application to the Hong Kong Stock Exchange, with SDIC Securities International as the sole sponsor.
2026-01-25
Conno Biopharmaceutical Co., Ltd.-B has submitted a listing application to the Hong Kong Stock Exchange, with SDIC Securities International as the sole sponsor.